Non-Alcoholic Fatty Liver Treatment - Viral Hepatitis and Liver Disease
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Viral Hepatitis and Liver Disease


Quick Links

Veterans Crisis Line Badge
My healthevet badge

Non-Alcoholic Fatty Liver Treatment

for Health Care Providers

Treatment - Non-Alcoholic Fatty Liver

How can we treat non-alcoholic fatty liver disease?

  • Intensive lifestyle intervention with ≥7% weight loss diminishes liver inflammation; ≥10% weight loss decreasing liver fibrosis. Motivational interviewing to engage patient to create their preferred plan, cognitive behavioral therapy, weight loss, diet, and exercise provide the most enduring benefit. For more on motivational interviewing for NAFLD, please see our video and pocket guide for providers.
  • As adjuncts to intensive lifestyle intervention,
    • weight loss pharmacotherapy can achieve 3-9% weight loss
    • bariatric surgery (up to 20-30% weight loss) may be considered if BMI≥40 kg/m2 or >35 with comorbidity (e.g., diabetes, HTN6)
  • With elevated ALT (for >6 months) or increased fibrosis prediction score (e.g. FIB-4), non-alcoholic steatohepatitis is more frequent and merits hepatology/GI referral for consideration of FibroScan or liver biopsy.
  • No NAFLD pharmacotherapy is currently licensed.


The Diagnosis and Management of Non-Alcoholic Fatty Liver DiseaseLink will take you outside the VA website. VA is not responsible for the content of the linked site.
Practice Guidance from the American Association for the Study of Liver Diseases; Hepatology, 2018